| CMR endpoint | Placebo | Erythropoietin | p Value |
|---|---|---|---|
| Mean myocardial area at risk (%) | 27.2±10.9 | 28.0±8.4 | p=0.8 |
| 24 h AUC Trop-T | 101.7±76.5 μg/l | 114.6±78.3 μg/l | p=0.56 |
| 24 h AUC CK-MB | 3649±2587 μg/l | 4682±2946 μg/l | p=0.20 |
| Mass of LGE (as % of AAR) | 67.8±24.0% | 71.5±17.0% | p=0.58 |
| Myocardial salvage index | 0.36±0.23 | 0.29±0.17 | p=0.28 |
| Microvascular obstruction (incidence) | 42% | 82% | p=0.02* |
| LV end diastolic volume (indexed) | 73±13 ml/m2 | 84±10 ml/m2 | p=0.003* |
| LV end systolic volume (indexed) | 34±11 ml/m2 | 41±9 ml/m2 | p=0.035* |
| LV ejection fraction | 53±10% | 51±7% | p=0.48 |